Early Access — free while we kick the tires
EdgarHawk

WALTERS GROUP

10% Owner

10% Owner
1 filing analyzed · 1 company · Latest 2026-01-08

Companies

Company Buys Sells Direction
Zentalis Pharmaceuticals, Inc. ZNTL 1 0 Net buying

Activity

January 2026
Buy
6,459,973 shares
$7,751,968
Significance 7/10

10% Owner WALTERS GROUP buys 6,459,973 shares of ZNTL at $1.20 ($7.8M), increasing stake to 13,509,973 shares (+91.6%)

WALTERS GROUP, a 10% shareholder, executed a substantial 6,459,973-share purchase at $1.20 per share, increasing aggregate holdings by 91.6% to 13,509,973 shares post-transaction. The acquisition occurred when the current stock price is $2.84—137% higher than the transaction price—and represents 30-day momentum of +105.8% and 90-day appreciation of +69.0%. Zentalis is unprofitable with $-26,691,000 net income and zero revenue in the latest quarter, placing this accumulation within a context of significant operational losses. The timing and scale of this stake increase—doubling down from 7.05M to 13.51M shares—merits examination of whether the insider expects a meaningful inflection in the underlying business or is responding to specific development milestones not yet visible in quarterly results.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access